Risk of being unable to continuously generate new candidate compounds
First written in FY2016. 6 of 7 entries say "Restated". Latest entry: FY2026.
2 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「However, there is no guarantee that our drug discovery approaches or screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While improving its drug discovery approaches and screening methods and obtaining new candidate compounds, the company states that continued generation of such compounds in the future is not guaranteed. - FY2023RestatedAnnual report
「However, there is no guarantee that our drug discovery approaches or screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While continuing to improve its screening methods and generate a next-generation pipeline, the company states that there is no guarantee it will be able to continuously generate new candidate compounds. - FY2022RestatedAnnual report
「However, there is no guarantee that our drug discovery approaches or screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While improving its drug discovery approaches and screening methods, the company states that there is no guarantee it will be able to continuously generate new candidate compounds. - FY2021RestatedAnnual report
「However, there is no guarantee that our drug discovery approaches or screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While pursuing the discovery and generation of new candidate compounds, the company states that there is no guarantee it will be able to generate them continuously. - FY2020RestatedAnnual report
「However, there is no guarantee that our drug discovery approaches or screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While continuing to improve its screening methods and generate a next-generation pipeline, the company states that there is no guarantee it will be able to continuously generate new candidate compounds. - FY2017RestatedAnnual report
「However, there is no guarantee that our screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While the company has a next-generation pipeline, it states that there is no guarantee it will be able to continuously generate new candidate compounds in the future. - FY2016First statedAnnual report
「However, there is no guarantee that our screening methods will enable us to discover and generate candidate compounds other than those already under development.」
While continuing to improve its drug discovery engine, the company states that future generation of new candidate compounds is not guaranteed.